BUSINESS

ACOG Recommends Hormone Therapy for Menopause

PUBLISHED Oct 16, 2026, 3:18 PM ET

Read, Watch or Listen

The American College of Obstetricians and Gynecologists has issued new guidance that positions hormone replacement therapy as the first‑line treatment for hot flashes and night sweats in many women. This marks the first change in more than a decade for the organization, which has long cautioned against routine use of hormones. The recommendation emphasizes starting therapy before the age of sixty or within ten years of menopause onset, and it highlights that newer research shows age and dosing can make treatment safe for many patients. Women with a history of blood clots, stroke, liver disease, or breast cancer should avoid hormone therapy, and alternative non‑hormonal options remain available for those who are ineligible. The guidance follows a 2002 long‑term study that raised concerns about breast‑cancer risk, but recent studies—including a 2024 analysis of over ten thousand women—suggest that hormone therapy can be safe and

By Nathan B. | JQJO News

Timeline of Events

2002 — Long‑term study links hormone use to breast‑cancer risk
2023 — Journal article calls for annual reassessment of hormone therapy
2024 — Study of ten thousand women shows hormone therapy can slow
On November 10 2025 FDA updates labeling for hormone therapy initiation guidelines.
2026 — JAMA publishes updated hormone therapy timing recommendations

News Intelligence

Immediate US impact: Women may access safer hormone treatments
Possible long-term US impact: Potential shift in menopause care standards
Most affected groups: Menopausal women and healthcare providers
Reader priority: Understand eligibility and safety guidelines

Explain Framing

Center: Coverage from CBS News frames this as a developing news story: ACOG Recommends Hormone Therapy for Menopause. Reporting emphasizes verified facts, named sources, and near-term impact for readers. Left: Left-leaning desks covering the same development typically emphasize public impact, institutional accountability, and who is most affected. Right: Right-leaning desks covering the same development typically emphasize practical outcomes, market or security stakes, and institutional response.